DNMT1 and neoplasm: CM-272 inhibits G9a, DNMT1, DNMT3A, and DNMT3B with an IC50 of 8 nM, 382 nM, 85 nM, and 1,200 nM, respectively (Figure 8), and promotes the apoptosis of various tumor cells in vitro.